Efficacy and Safety of 177Lu-PSMA-617 in Combination with Radical Prostatectomy and Bilateral Orchiectomy in Men with Castrate-Sensitive Metastatic Prostate Cancer: A Pilot Study.
This pilot study suggests that radical prostatectomy and hormonal therapy in combination with 177Lu-PSMA-617 is a safe and effective treatment option and may have a role in the management of select patients with castrate-sensitive metastatic prostate cancer. Further studies are needed to confirm these findings and determine the optimal use in this setting.
Authors
- N. Simforoosh
- Saber Amanollahi Soudmand
- Samaneh Hoseinzadeh
- Maryam Moosavi (ORCID: https://orcid.org/0000-0001-6943-477X)
Institutions
- Research Institute for Endocrine Sciences (IR)
- Shahid Beheshti University (IR)
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- PubMed
- Published
- 2024-11-27
- DOI
- https://doi.org/10.22037/uj.v21i.8101
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00